uniQure N.V (NASDAQ:QURE) has a beta value of 0.35 and has seen 0.88 million shares traded in the recent trading session. The company, currently valued at $553.21M, closed the recent trade at $10.23 per share which meant it lost -$2.24 on the day or -17.96% during that session. The QURE stock price is -87.49% off its 52-week high price of $19.18 and 63.54% above the 52-week low of $3.73. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.16 million shares traded. The 3-month trading volume is 1.07 million shares.
The consensus among analysts is that uniQure N.V (QURE) is Buy stock at the moment, with a recommendation rating of 1.31. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 7 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.97.
uniQure N.V (NASDAQ:QURE) trade information
Sporting -17.96% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the QURE stock price touched $10.23 or saw a rise of 31.66%. Year-to-date, uniQure N.V shares have moved -42.07%, while the 5-day performance has seen it change -30.74%. Over the past 30 days, the shares of uniQure N.V (NASDAQ:QURE) have changed -22.21%. Short interest in the company has seen 3.05 million shares shorted with days to cover at 3.22.
Wall Street analysts have a consensus price target for the stock at $27, which means that the shares’ value could jump 62.11% from the levels at last check today.. The projected low price target is $24.0 while the price target rests at a high of $30.0. In that case, then, we find that the latest price level in today’s session is -193.26% off the targeted high while a plunge would see the stock gain -134.6% from the levels at last check today..
uniQure N.V (QURE) estimates and forecasts
The company’s shares have gained 105.63% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 51.73%.
9 analysts offering their estimates for the company have set an average revenue estimate of 5.88M for the current quarter. 9 have an estimated revenue figure of 6.72M for the next ending quarter. Year-ago sales stood 7.87M and 10.32M respectively for this quarter and the next, and analysts expect sales will shrink by -25.29% for the current quarter and 51.73% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.66% over the past 5 years. Earnings growth for 2025 is a modest 21.10% while over the next 5 years, the company’s earnings are expected to increase by 31.22%.
QURE Dividends
uniQure N.V is expected to release its next earnings report on 2025-Feb-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
uniQure N.V (NASDAQ:QURE)’s Major holders
Insiders own 8.59% of the company shares, while shares held by institutions stand at 77.62% with a share float percentage of 84.92%. Investors are also buoyed by the number of investors in a company, with uniQure N.V having a total of 170.0 institutions that hold shares in the company. The top two institutional holders are VESTAL POINT CAPITAL, LP with over 4.75 million shares worth more than $21.28 million. As of 2024-06-30, VESTAL POINT CAPITAL, LP held 9.7692% of shares outstanding.
The other major institutional holder is NANTAHALA CAPITAL MANAGEMENT, LLC, with the holding of over 2.65 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.87 million and represent 5.4511% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are abrdn Healthcare Investors and Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND . As of Dec 31, 2024 , the former fund manager holds about 1.50% shares in the company for having 812.69 shares of worth $8.22 million while later fund manager owns 733.5 shares of worth $7.42 million as of Jan 31, 2025 , which makes it owner of about 1.36% of company’s outstanding stock.
